{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Daniele G"],"funding":["NCATS NIH HHS","NIDDK NIH HHS"],"pagination":["2812-20"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC4113069"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["63(8)"],"pubmed_abstract":["Insulin resistance and dysregulation of free fatty acid (FFA) metabolism are core defects in type 2 diabetic (T2DM) and obese normal glucose tolerant (NGT) individuals. Impaired muscle mitochondrial function (reduced ATP synthesis) also has been described in insulin-resistant T2DM and obese subjects. We examined whether reduction in plasma FFA concentration with acipimox improved ATP synthesis rate and altered reactive oxygen species (ROS) production. Eleven NGT obese and 11 T2DM subjects received 1) OGTT, 2) euglycemic insulin clamp with muscle biopsy, and 3) (1)H-magnetic resonance spectroscopy of tibialis anterior muscle before and after acipimox (250 mg every 6 h for 12 days). ATP synthesis rate and ROS generation were measured in mitochondria isolated from muscle tissue ex vivo with c"],"journal":["Diabetes"],"pubmed_title":["Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individuals."],"pmcid":["PMC4113069"],"funding_grant_id":["UL1 TR001120","R01 DK024092","5R01-DK-240923","KL2 TR001118","K25 DK089012"],"pubmed_authors":["Merovci A","Xiong J","Daniele G","Clarke GD","DeFronzo RA","Taranova A","Abdul-Ghani M","Eldor R","Tripathy D"],"additional_accession":[]},"is_claimable":false,"name":"Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individuals.","description":"Insulin resistance and dysregulation of free fatty acid (FFA) metabolism are core defects in type 2 diabetic (T2DM) and obese normal glucose tolerant (NGT) individuals. Impaired muscle mitochondrial function (reduced ATP synthesis) also has been described in insulin-resistant T2DM and obese subjects. We examined whether reduction in plasma FFA concentration with acipimox improved ATP synthesis rate and altered reactive oxygen species (ROS) production. Eleven NGT obese and 11 T2DM subjects received 1) OGTT, 2) euglycemic insulin clamp with muscle biopsy, and 3) (1)H-magnetic resonance spectroscopy of tibialis anterior muscle before and after acipimox (250 mg every 6 h for 12 days). ATP synthesis rate and ROS generation were measured in mitochondria isolated from muscle tissue ex vivo with c","dates":{"release":"2014-01-01T00:00:00Z","publication":"2014 Aug","modification":"2025-05-18T10:34:52.986Z","creation":"2025-05-18T10:34:52.986Z"},"accession":"S-EPMC4113069","cross_references":{"pubmed":["24353180"],"doi":["10.2337/db13-1130"]}}